Biomerica, Inc. BMRA
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.60% | 12.73% | 0.61% | -66,100.00% | 100.13% |
| Total Depreciation and Amortization | -28.83% | 5.71% | 1.94% | 0.98% | -1.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 145.75% | -717.50% | -61.90% | -41.01% | 12.66% |
| Change in Net Operating Assets | -35.50% | 544.58% | -168.60% | 122.00% | -188.71% |
| Cash from Operations | 12.06% | 27.04% | -26.14% | -269.78% | 59.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 194.74% | -- | -- | -- |
| Cash from Investing | -- | 194.74% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 488.65% | 501.59% | -87.22% | -47.50% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -300.00% | 81.82% | 42.11% | -375.00% |
| Cash from Financing | 156.14% | 1,327.87% | -87.34% | -47.61% | 18,500.00% |
| Foreign Exchange rate Adjustments | 20.00% | -600.00% | 200.00% | -150.00% | -75.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,189.29% | 97.68% | -136.67% | -177.98% | 199.24% |